News

This is the third cancer indication being explored by Aveo for the potential combined use of AV-951 with leading targeted agents or chemotherapeutic regimens. The company has launched

The trial will enroll 16 ambulatory boys with Duchenne muscular dystrophy (DMD) and initially evaluate multiple intravenous doses of AVI-4658 between 0.5-4mg/kg. This is an open label, 12

Medtronic said that this acquisition adds two technologies to its transcatheter valve portfolio: a minimally invasive, surgical transapical technology and a next generation percutaneous, transfemoral technology. These complementary

Kapidex, available in 30mg and 60mg doses, was recently approved by the FDA for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing

The appointment concludes the executive search undertaken by the board of directors in November 2008 to identify a replacement for Richard Damron, Jr, who served in the same

The Phase II trial, also called the ‘Precedent study’, will evaluate the efficacy and safety of EC145 when administered in combination with pegylated liposomal doxorubicin (PLD). PLD is

In this position, Mr Lytton will be responsible for leading the company’s business development activities. From 2001 to 2009, Mr Lytton served as a general partner at Oxford

The purchase price of the Alveolus assets is approximately $19 million, subject to post-closing adjustments. The Alveolus assets consist primarily of an intellectual property portfolio, inventory, receivables and

Results of a study conducted by a research group at The University of Hong Kong through a collaboration with Novavax showed 100% survival of mice immunized with this